This article is part of the supplement: Basic science, rationale, background and future of abatacept

Highly Accessed Review

The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis

Eric M Ruderman* and Richard M Pope

Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 doi:10.1186/ar1688

Accesses  

  • Last 30 days: 114 accesses
  • Last 365 days: 1196 accesses
  • All time: 13237 accesses

Cited by

BioMed Central: 4 citations

Google Scholar: View citations

PubMed Central: View citations